Cargando…
The Circadian Gene NPAS2 Act as a Putative Tumor Stimulative Factor for Uterine Corpus Endometrial Carcinoma
BACKGROUND: Mounting evidence indicates altered circadian rhythm represents a critical factor affecting carcinogenesis and tumor progression. The circadian gene neuronal PAS domain protein 2 (NPAS2) constitutes a newly discovered prognostic biomarker. NPAS2 dysregulation is found in multiple maligna...
Autores principales: | Zheng, Xiaojiao, Lv, Xiuyi, Zhu, Linyan, Xu, Kejun, Shi, Cong, Cui, Lining, Ding, Huiqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8711112/ https://www.ncbi.nlm.nih.gov/pubmed/34992456 http://dx.doi.org/10.2147/CMAR.S343097 |
Ejemplares similares
-
MiR-486-5p Act as a Biomarker in Endometrial Carcinoma: Promotes Cell Proliferation, Migration, Invasion by Targeting MARK1
por: Zheng, Xiaojiao, et al.
Publicado: (2020) -
RTN2, a new member of circadian clock genes identified by database mining and bioinformatics prediction, is highly expressed in ovarian cancer
por: Zheng, Xiaojiao, et al.
Publicado: (2022) -
NPAS2 Compensates for Loss of CLOCK in Peripheral Circadian Oscillators
por: Landgraf, Dominic, et al.
Publicado: (2016) -
Role of the Circadian Gas-Responsive Hemeprotein NPAS2 in Physiology and Pathology
por: Murgo, Emanuele, et al.
Publicado: (2023) -
Matrix metalloproteinase-7 may serve as a novel biomarker for cervical cancer
por: Zhu, Linyan, et al.
Publicado: (2018)